Imaging artificial intelligence vendor Elucid raises $55M
The Boston AI firm touted the “oversubscribed” Series D funding round, which included participation from an unnamed, publicly traded medical technology firm.
The Boston AI firm touted the “oversubscribed” Series D funding round, which included participation from an unnamed, publicly traded medical technology firm.
What's Your Reaction?
